西艾克临床疗效观察

OBSERVATION ON CLINICAL EFFICACY OF VINDESINE

对42例经病理组织学证实患者行西艾克临床试验观察,其中单药组13例,联合治疗组20例,对照组9例。结果:单药组有效率46.2%,联合组65%,对照组66.7%。联合治疗组以乳腺癌疗效最佳。本药骨髓抑制轻微,消化道反应轻。可作为一线联合化疗方案的组成药物之一。

42 patients whom are diagnosed to be cancer were divided into only vindesine group of 13 patients,combined theraputic group of 20 patients and control group of 9 patients.The remission rate are 46.2% for only vindesine group,65% forcombined theraputic group,and 66. 7% for control group.Vindesine is effective inNSCCL,brest cancer,and malignant lymphomas and nausea,vomiting and phlibitis areits major side effects.